Home  |  Contact
Due to work on this service, it may not be fully operational on Wednesday March 20 between 1.30 pm and 2.30 pm CEST. Apologies for the incovenience.

Cellosaurus LB831-BLC (CVCL_1370)

[Text version]

Cell line name LB831-BLC
Synonyms LB831BLC; LB831
Accession CVCL_1370
Resource Identification Initiative To cite this cell line use: LB831-BLC (RRID:CVCL_1370)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Part of: COSMIC cell lines project.
From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Omics: Transcriptome analysis.
Disease Bladder carcinoma (NCIt: C4912)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual CVCL_E913 ! LB831-EBV
Sex of cell Male
Category Cancer cell line
STR profile Source(s): Cosmic-CLP

Markers:
AmelogeninX
CSF1PO12
D5S81812,13
D7S82010,12
D13S3178
D16S53912
TH018,9
TPOX8,10
vWA16,17
Publications

PubMed=9637538
Gueguen M., Patard J.-J., Gaugler B., Brasseur F., Renauld J.-C., Van Cangh P.J., Boon T., van den Eynde B.J.
An antigen recognized by autologous CTLs on a human bladder carcinoma.
J. Immunol. 160:6188-6194(1998)

PubMed=11051255
Gala J.-L., Loric S., Guiot Y., Denmeade S.R., Gady A., Brasseur F., Heusterspreute M., Eschwege P., De Nayer P., Van Cangh P.J., Tombal B.
Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value?
Clin. Cancer Res. 6:4049-4054(2000)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=29732388; DOI=10.3233/BLC-180167
Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.
Systematic review: characteristics and preclinical uses of bladder cancer cell lines.
Bladder Cancer 4:169-183(2018)

Cross-references
Cell line databases/resources CCLE; LB831BLC_URINARY_TRACT
Cell_Model_Passport; SIDM00181
Cosmic-CLP; 753584
GDSC; 753584
LINCS_LDP; LCL-1707
TOKU-E; 3997
Chemistry resources ChEMBL-Cells; CHEMBL3308853
ChEMBL-Targets; CHEMBL2366222
Gene expression databases ArrayExpress; E-MTAB-3610
GEO; GSM1670039
Other Wikidata; Q54902093
Polymorphism and mutation databases Cosmic; 753584